Adeno-associated virus delivery of cln3 polynucleotide
AssigneesResearch Institute At Nationwide Children's Hospital, Ohio State Innovation Foundation
InventorsKathrin Meyer, Brian K. Kaspar, Kevin Foust
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to recombinant adeno-associated virus (rAAV) delivery of a ceroid lipofuscinosis neuronal 3 (CLN3) polynucleotide. The disclosure provides rAAV and methods of using the rAAV for CLN3 gene therapy of the neuronal ceroid lipofuscinosis or CLN3-Batten Discase.
Claims14
1-71. (canceled)
A DNA plasmid comprising a recombinant adeno-associate virus (rAAV) genome, wherein the rAAV genome comprises a nucleotide sequence having at 90% sequence similarity to the nucleic acid sequence of SEQ ID NO:
- 4
The DNA plasmid of clam 72, wherein the rAAV genome is a single-stranded genome.
Dependencies are inferred from the claim text.